申请人:[en]OMASS THERAPEUTICS LIMITED
公开号:WO2023148481A1
公开(公告)日:2023-08-10
The disclosures herein relate to novel compounds of Formula (1a) or a salt thereof, wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, Z1, Z2, Z3, Z4, W, R1, R4, R5, R6and R7are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with SMO receptors.